Clinical Trial Update: The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating moderate versus aggressive treatment with valsartan plus amlodipine in hypertension patients uncontrolled on ARB monotherapy; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• DIOVAN (valsartan)
• NORVASC (amlodipine besylate)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2010-12-10